Filing Details
- Accession Number:
- 0001209191-12-045604
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-14 17:06:43
- Reporting Period:
- 2012-09-12
- Filing Date:
- 2012-09-14
- Accepted Time:
- 2012-09-14 17:06:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1472595 | Accretive Health Inc. | AH | Services-Management Services (8741) | 020698101 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1200675 | Jr Edgar Bronfman | C/O Accretive Health, Inc. 401 North Michigan Avenue, Suite 2700 Chicago IL 60611 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-09-12 | 40,300 | $13.16 | 473,483 | No | 4 | S | Indirect | Refer to footnote |
Common Stock | Disposition | 2012-09-13 | 209,700 | $12.16 | 263,783 | No | 4 | S | Indirect | Refer to footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Refer to footnote |
No | 4 | S | Indirect | Refer to footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,156,092 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.44, inclusive. The reporting person undertakes to provide to Accretive Health, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
- Represents shares of common stock of the Issuer held by Lexa Partners II LLC ("Lexa Partners"). Trusts and custodians for the benefit of the children of the Reporting Person are members of Lexa Partners. The Reporting Person is not a member of Lexa Partners nor a trustee or custodian of the members of Lexa Partners, and the Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the common stock held by Lexa Partners.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.88, inclusive.